← All Agilon Health, INC filings

Agilon Health, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
AGL
Agilon Health, INC
DEF: agilon health 2026 Proxy Statement Overview
agilon health's 2026 proxy statement outlines leadership transitions, executive compensation adjustments, and strategic focus on profitability.
NYSE
AGL
Agilon Health, INC
DEFA14A: Agilon Health Files Supplement to Correct Executive Compensation and Ownership Details
Agilon Health files a supplement to its definitive proxy statement to correct information regarding executive compensation, beneficial ownership, and proxy solicitation.
NYSE
AGL
Agilon Health, INC
DEFA14A: Agilon Health, Inc. Files Definitive Proxy Statement
Agilon Health, Inc. has filed a definitive proxy statement with the SEC related to its upcoming shareholder meeting.
NYSE
AGL
Agilon Health, INC
DEF: Agilon Health Faces Shareholder Vote Amidst Executive Changes and Financial Challenges
Agilon Health's proxy statement reveals a company navigating a complex industry transition, executive leadership changes, and a focus on achieving cash flow breakeven by 2027, all while seeking shareholder approval on key governance matters.
NYSE
AGL
Agilon Health, INC
DEFA14A: Agilon Health Files Definitive Proxy Statement with SEC
Agilon Health has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
AGL
Agilon Health, INC
DEF 14A: Agilon Health Files Definitive Proxy Statement for 2024 Annual Meeting
Agilon Health has released its definitive proxy statement, outlining proposals for the upcoming annual meeting of stockholders scheduled for May 29, 2024.